AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization

Abstract We here present AutoGrow4, an open-source program for semi-automated computer-aided drug discovery. AutoGrow4 uses a genetic algorithm to evolve predicted ligands on demand and so is not limited to a virtual library of pre-enumerated compounds. It is a useful tool for generating entirely no...

Full description

Bibliographic Details
Main Authors: Jacob O. Spiegel, Jacob D. Durrant
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Journal of Cheminformatics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13321-020-00429-4
id doaj-7cce4e0db5d64d7e83f78e6dc9d1c40e
record_format Article
spelling doaj-7cce4e0db5d64d7e83f78e6dc9d1c40e2020-11-25T03:00:27ZengBMCJournal of Cheminformatics1758-29462020-04-0112111610.1186/s13321-020-00429-4AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimizationJacob O. Spiegel0Jacob D. Durrant1Department of Biological Sciences, University of PittsburghDepartment of Biological Sciences, University of PittsburghAbstract We here present AutoGrow4, an open-source program for semi-automated computer-aided drug discovery. AutoGrow4 uses a genetic algorithm to evolve predicted ligands on demand and so is not limited to a virtual library of pre-enumerated compounds. It is a useful tool for generating entirely novel drug-like molecules and for optimizing preexisting ligands. By leveraging recent computational and cheminformatics advancements, AutoGrow4 is faster, more stable, and more modular than previous versions. It implements new docking-program compatibility, chemical filters, multithreading options, and selection methods to support a wide range of user needs. To illustrate both de novo design and lead optimization, we here apply AutoGrow4 to the catalytic domain of poly(ADP-ribose) polymerase 1 (PARP-1), a well characterized DNA-damage-recognition protein. AutoGrow4 produces drug-like compounds with better predicted binding affinities than FDA-approved PARP-1 inhibitors (positive controls). The predicted binding modes of the AutoGrow4 compounds mimic those of the known inhibitors, even when AutoGrow4 is seeded with random small molecules. AutoGrow4 is available under the terms of the Apache License, Version 2.0. A copy can be downloaded free of charge from http://durrantlab.com/autogrow4 .http://link.springer.com/article/10.1186/s13321-020-00429-4AutogrowGenetic algorithmComputer-aided drug designVirtual screeningPARP-1
collection DOAJ
language English
format Article
sources DOAJ
author Jacob O. Spiegel
Jacob D. Durrant
spellingShingle Jacob O. Spiegel
Jacob D. Durrant
AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
Journal of Cheminformatics
Autogrow
Genetic algorithm
Computer-aided drug design
Virtual screening
PARP-1
author_facet Jacob O. Spiegel
Jacob D. Durrant
author_sort Jacob O. Spiegel
title AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
title_short AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
title_full AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
title_fullStr AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
title_full_unstemmed AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
title_sort autogrow4: an open-source genetic algorithm for de novo drug design and lead optimization
publisher BMC
series Journal of Cheminformatics
issn 1758-2946
publishDate 2020-04-01
description Abstract We here present AutoGrow4, an open-source program for semi-automated computer-aided drug discovery. AutoGrow4 uses a genetic algorithm to evolve predicted ligands on demand and so is not limited to a virtual library of pre-enumerated compounds. It is a useful tool for generating entirely novel drug-like molecules and for optimizing preexisting ligands. By leveraging recent computational and cheminformatics advancements, AutoGrow4 is faster, more stable, and more modular than previous versions. It implements new docking-program compatibility, chemical filters, multithreading options, and selection methods to support a wide range of user needs. To illustrate both de novo design and lead optimization, we here apply AutoGrow4 to the catalytic domain of poly(ADP-ribose) polymerase 1 (PARP-1), a well characterized DNA-damage-recognition protein. AutoGrow4 produces drug-like compounds with better predicted binding affinities than FDA-approved PARP-1 inhibitors (positive controls). The predicted binding modes of the AutoGrow4 compounds mimic those of the known inhibitors, even when AutoGrow4 is seeded with random small molecules. AutoGrow4 is available under the terms of the Apache License, Version 2.0. A copy can be downloaded free of charge from http://durrantlab.com/autogrow4 .
topic Autogrow
Genetic algorithm
Computer-aided drug design
Virtual screening
PARP-1
url http://link.springer.com/article/10.1186/s13321-020-00429-4
work_keys_str_mv AT jacobospiegel autogrow4anopensourcegeneticalgorithmfordenovodrugdesignandleadoptimization
AT jacobddurrant autogrow4anopensourcegeneticalgorithmfordenovodrugdesignandleadoptimization
_version_ 1724698102166716416